Blue Cross and Blue Shield of Louisiana, HMO Louisiana, Inc. et al. v. Janssen Biotech, Inc. et al.
Blue Cross and Blue Shield of Louisiana, HMO Louisiana, Inc. et al. v. Janssen Biotech, Inc. et a (N.D.J.): Cohen Milstein represents the City of Baltimore in this antitrust class action against Janssen Biotech, Inc., Janssen Oncology, Inc., Janssen Research & Development LLC (collectively, “Janssen”) and BTG International Limited (“BTG”), a global healthcare company. Plaintiffs allege that the defendants engaged in anticompetitive conduct preventing generic manufacturers from entering the market with competing abiraterone acetate products for more than year, delayed the entry of additional generic competitors, and has cost purchasers hundreds of millions of dollars in overcharge damages.
Brown v. JBS USA Food Company, et al.
Brown v. JBS USA Food Company, et al. (D. Colo.): Cohen Milstein serves as Interim Co-Lead Counsel in this wage suppression antitrust class action against eleven of country’s largest beef and pork producers and several of their subsidiaries, including JBS USA Food, Tyson Foods, Cargill, Hormell Foods, American Foods, Perdue Farms, Smithfield Foods, and National Beef Packing. On March 8, 2024, Plaintiffs filed motions for preliminary approval of a total $127.2 million in settlements against Tyson Foods and JBS USA Food. If granted approval by the court, preliminarily approved settlements will total $138.5 million.
Ideker Farms, Inc., et al. v. United States of America (NW Missouri Flood Litigation)
Ideker Farms, et al. v. United States of America (Fed. Cl.): Cohen Milstein represents Ideker Farms and more than 400 other plaintiffs located in six states along the Missouri River in a landmark mass action lawsuit in the U.S. Court of Federal Claims alleging that the federal government took land and flooding easements over lands owned by farmers without any compensation in violation of the takings clause of the Fifth Amendment. Cohen Milstein has helped lead the litigation team, including during both a months-long liability trial in 2017, and a subsequent damages trial in 2020 for bellwether plaintiffs. In December 2020, the Court ruled largely in favor of bellwether plaintiffs. In June 2023, the U.S. Court of Appeals for the Federal Circuit concurred with the lower court and reversed and remanded the issues of compensation for lost crops and 2011 flooding to the lower court to determine valuation.
In re Actos End Payor Antitrust Litigation
In re Actos Antitrust Litigation (S.D.N.Y.): Cohen Milstein represents End-Payor Plaintiffs in this antitrust action, alleging that Defendant Takeda engaged in anticompetitive conduct related to the listing of certain patents in the FDA’s Orange Book thereby resulting in unlawful delays to the market entry of generic versions of Takeda’s diabetes drug, Actos.
In Re Axon VieVu Antitrust Litigation
In Re Axon VieVu Antitrust Litigation (D.N.J.): Cohen Milstein, as Co-Lead Counsel, represents the Mayor and City Council of Baltimore and other municipalities in this consolidated antitrust class action, alleging that Axon unlawfully monopolized the markets for body-worn camera systems and long-range conducted energy weapons, such as Tasers, through acquiring its largest competitor and signing decade-long non-compete, market allocation, and no-poach agreements with its main competitor.
In re Broiler Chicken Antitrust Litigation
In re Broiler Chicken Antitrust Litigation (N.D. Ill.): Cohen Milstein represents a class of broiler chicken consumers in a suit alleging that the nation’s largest chicken producers, including Perdue Farms and Tyson Foods, conspired to raise the price of chicken. On December 20, 2021, the Court granted final approval of settlements with six of the defendants for a total of $181 million. Litigation against the remaining defendants continues.
In re Bystolic Antitrust Litigation
In re Bystolic Antitrust Litigation (S.D.N.Y.): Plaintiffs allege that Forest Laboratories Inc., now a part of AbbVie, engaged in an illegal scheme with pharmaceutical generic manufacturers not to make generic versions of Bystolic®, a hypertension prescription medication containing the active pharmaceutical ingredient nebivolol hydrochloride.
In re Crop Protection Products Loyalty Program Antitrust Litigation
In re Crop Protection Products Loyalty Program Antitrust Litigation (M.D.N.C.): Cohen Milstein serves as Interim Co-Lead Class Counsel in this antirust multidistrict litigation against Syngenta Crop Protection and Corteva, Inc., two of the world’s largest pesticide manufactures. Plaintiffs allege these Defendants have illegally blocked competition through exclusive distributor “loyalty agreements,” thereby forcing farmers to pay supracompetitive prices while restricting their ability to benefit from new, innovative products.
In re Da Vinci Surgical Robot Antitrust Litigation
In re Da Vinci Surgical Robot Antitrust Litigation (N.D. Cal.): Cohen Milstein serves as Interim Co-Lead Counsel in this consolidated antitrust class action against Intuitive Surgical, Inc. Plaintiffs allege that Intuitive engages in an anticompetitive scheme under which it ties the purchase or lease of its must-have, market-dominating da Vinci surgical robot to the additional purchases of (i) robot maintenance and repair services and (ii) unnecessarily large numbers of the surgical instruments, known as EndoWrists, used to perform surgery with the robot—a violation of Sections 1 and 2 of the Sherman Act.